Navigation Links Issues MarketStats on Agri-Biotech Equities YGYB, GRO, SEED, MON, ADM, and BG

IRVINE, Calif., Sept. 9 /PRNewswire/ -- announces the availability of MarketStats for agri-biotech equities in the news and driving markets today. MarketStats offers a perspective on the aforementioned equities and the opportunity for investors to respond with articles, blogs and opinions.

Investors can view MarketStats by visiting: -- a division of, a dynamic social networking site for investors.

Today's MarketStats for agri-biotech companies include Yongye Biotechnology International, Inc. (OTC Bulletin Board: YGYB) Agria Corporation (Agria) (NYSE: GRO), Origin Agritech Limited (Nasdaq: SEED), Monsanto Company (NYSE: MON), Archer Daniels Midland Company (NYSE: ADM) and Bunge Limited (Bunge) (NYSE: BG).

For a fact sheet by, visit the following link: is the premiere Internet destination for stock market readers and writers, allowing individuals to post blogs, articles, messages and more in organized sector channels, creating the effective exchange of ideas. By posting content on individuals can acquire F.A.N.S. (Financial Networked Subscribers) who help increase the author's influence and standing on the site in an unprecedented way. is powered by Market Pathways, a leader in the representation of Small Cap equities for nearly thirty years. Market Pathways' analyst Brian Kelly holds CRD #2880975. To be featured in our publications please use the number below.

Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results., and are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect proposed actions and cannot project capabilities, intent, resources, or experience. The subject companies have not always approved the statements made in this report. This report is neither a solicitation to buy nor an offer to sell securities but is for information purposes only and should not be used as the basis for any investment decision. MP is not an investment advisor, analyst or licensed broker dealer and this report is not investment advice. MP has been paid 1,500 dollars by for preparation and distribution of this report and other advertising services. This constitutes a conflict of interest as to MP's ability to remain objective in its communication regarding the subject company.

Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Issues MarketStats on CVBT, BSX, MDT, CXM and DNA
2. Issues MarketStats on KBLB, DGX, LH, BRLI, and ABT
3. Pharmos Issues Letter to Shareholders
4. MichBio Issues 2007/8 Michigan Life Sciences Directory and Resources Guide
5. HHS Issues First Department-Wide Report on Personalized Health Care
6. CalbaTech Issues Update; Beginning Training for Adult Stem Cell Collections in Atlanta
7. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
8. CCPM Issues Statement on FDAs GIVE Initiative
9. Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants
10. FDA Issues Approvable Letter for LUVOX(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)
11. Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials
Post Your Comments:
(Date:11/25/2015)... November 25, 2015 Studies reveal ... human plaque and pave the way for more effective treatment ... cats     --> ... diagnosed health problems in cats, yet relatively little was understood ... collaborative studies have been conducted by researchers from the WALTHAM ...
(Date:11/25/2015)... 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... a fireside chat discussion at the Piper Jaffray 27th ... . The discussion is scheduled for Wednesday, December 2, ... .  A replay will be available for 14 days ... , Julie NormartVP, Corporate Communications and Business Development , ...
(Date:11/24/2015)... 2015 Cepheid (NASDAQ: CPHD ) today ... following conference, and invited investors to participate via webcast. ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern Time ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern Time ... New York, NY      Tuesday, December 1, 2015 ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
Breaking Biology Technology:
(Date:11/12/2015)... 11, 2015   Growing need for low-cost, ... has been paving the way for use of ... discrete analytes in clinical, agricultural, environmental, food and ... used in medical applications, however, their adoption is ... to continuous emphasis on improving product quality and ...
(Date:11/10/2015)... Nov. 10, 2015 About ... that helps to identify and verify the identity ... considered as the secure and accurate method of ... a particular individual because each individual,s signature is ... especially when dynamic signature of an individual is ...
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
Breaking Biology News(10 mins):